Paper31344348
Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer.
Jiménez-Vacas JM and 14 others. Transl Res, 2019. Cited by 73 papers, by iCite.
Cite this record
ConductScience Library. Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer. Papers, record 31344348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31344348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Biomarkers, Tumor | Major topic |
| Phosphoproteins | Major topic |
| Prostatic Neoplasms | Major topic |
| RNA Splicing Factors | Major topic |
| Aged | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Cohort Studies | |
| Drug Delivery Systems | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Spliceosomes |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42936122 | The long non-coding RNA LINC01089 facilitates prostate cancer progression. | BBA Adv | 2026 | https://conductscience.org/library/papers/42936122 | PubMed |
| 42716948 | Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/42716948 | PubMed |
| 42649859 | The Role of Splicing Machinery as a Promising Potential Therapeutic Target for Pituitary Neuroendocrine Tumors (PitNETs). | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42649859 | PubMed |
| 42602702 | Pathophysiological and translational implications of the dysregulation of molecular machineries controlling RNA metabolism in thyrotropinomas. | iScience | 2026 | https://conductscience.org/library/papers/42602702 | PubMed |
| 42363275 | Proteomics-based approach reveals the involvement of spliceosomal components SF3B and SerpinB9 in dermatofibrosarcoma protuberans. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/42363275 | PubMed |
| 42103729 | Synergistic effect of Pladienolide B and cisplatin: enhancing autophagy in hepatoma cells through the AMPK/mTOR/ULK1 pathway. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42103729 | PubMed |
| 42013849 | Plasma extracellular vesicle proteomics nominates candidate biomarkers of 177Lu-PSMA-617 outcomes in metastatic prostate cancer patients. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42013849 | PubMed |
| 41919503 | Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers. | J Clin Invest | 2026 | https://conductscience.org/library/papers/41919503 | PubMed |
| 41179739 | Dysregulation of mRNA splicing in urothelial carcinoma: Clinical, diagnostic and therapeutic implications. | Bladder Cancer | 2025 | https://conductscience.org/library/papers/41179739 | PubMed |
| 40581690 | Impaired splicing machinery in craniopharyngiomas unveils PRPF8 and RAVER1 as novel biomarkers and therapeutic targets. | Acta Neuropathol Commun | 2025 | https://conductscience.org/library/papers/40581690 | PubMed |
| 39885614 | Targeting RNA splicing modulation: new perspectives for anticancer strategy? | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/39885614 | PubMed |
| 39758250 | Clinical value of circulating splicing factors in prostate cancer: SRRM1 as a novel predictive biomarker and therapeutic target. | Mol Ther Oncol | 2024 | https://conductscience.org/library/papers/39758250 | PubMed |
| 39725737 | The splicing machinery is dysregulated and represents a therapeutic vulnerability in breast cancer. | Cell Mol Life Sci | 2024 | https://conductscience.org/library/papers/39725737 | PubMed |
| 39574470 | Caffeic acid hinders the proliferation and migration through inhibition of IL-6 mediated JAK-STAT-3 signaling axis in human prostate cancer. | Oncol Res | 2024 | https://conductscience.org/library/papers/39574470 | PubMed |
| 39356765 | SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer. | Sci Adv | 2024 | https://conductscience.org/library/papers/39356765 | PubMed |
| 39348093 | Defining Splicing Factor Requirements for Androgen Receptor Variant Synthesis in Advanced Prostate Cancer. | Mol Cancer Res | 2024 | https://conductscience.org/library/papers/39348093 | PubMed |
| 39275340 | The Protective Effects of an Aged Black Garlic Water Extract on the Prostate. | Nutrients | 2024 | https://conductscience.org/library/papers/39275340 | PubMed |
| 39127833 | The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11. | Cancer Gene Ther | 2024 | https://conductscience.org/library/papers/39127833 | PubMed |
| 39009593 | Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. | Nat Commun | 2024 | https://conductscience.org/library/papers/39009593 | PubMed |
| 39000035 | Splicing Machinery Is Impaired in Oral Squamous Cell Carcinomas and Linked to Key Pathophysiological Features. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39000035 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| MAPK8 | 5599 | PubTator's text mining | https://conductscience.org/library/genes/5599 | NCBI Gene |
| SF3B1 | 23451 | PubTator's text mining | https://conductscience.org/library/genes/23451 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31344348
GET https://conductscience.org/api/papers/v1/31344348/cited_by?page=2